Boni Ding

525 total citations
23 papers, 303 citations indexed

About

Boni Ding is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Boni Ding has authored 23 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Boni Ding's work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Cancer and Skin Lesions (4 papers). Boni Ding is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Cancer and Skin Lesions (4 papers). Boni Ding collaborates with scholars based in China, United Kingdom and Slovakia. Boni Ding's co-authors include Liyuan Qian, Wei Wu, Xuedong Chen, Jianbin Tong, Juan Zhang, Jufang Huang, Yujun Zhao, Ling Wang, Yuhui Wu and Qin Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Pollution and European Journal of Cancer.

In The Last Decade

Boni Ding

20 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boni Ding China 9 159 125 56 56 38 23 303
Chunchun Zhi China 7 206 1.3× 100 0.8× 87 1.6× 75 1.3× 32 0.8× 9 322
Linglong Peng China 11 124 0.8× 58 0.5× 47 0.8× 71 1.3× 43 1.1× 33 288
Xinwei Xu China 12 219 1.4× 51 0.4× 57 1.0× 111 2.0× 23 0.6× 20 344
Benjamin J. Huang United States 11 224 1.4× 93 0.7× 73 1.3× 65 1.2× 24 0.6× 44 461
Jian Chu China 9 193 1.2× 85 0.7× 32 0.6× 89 1.6× 56 1.5× 32 303
Qianjing Zhang China 10 279 1.8× 78 0.6× 67 1.2× 111 2.0× 42 1.1× 20 407
Susanne Bentz Switzerland 8 193 1.2× 75 0.6× 42 0.8× 72 1.3× 19 0.5× 9 352
Apple Long United States 6 208 1.3× 132 1.1× 51 0.9× 98 1.8× 47 1.2× 8 375
Maria Sifaki Greece 10 131 0.8× 54 0.4× 44 0.8× 32 0.6× 33 0.9× 12 347
Shuangshuang Lu China 12 143 0.9× 133 1.1× 49 0.9× 71 1.3× 46 1.2× 31 338

Countries citing papers authored by Boni Ding

Since Specialization
Citations

This map shows the geographic impact of Boni Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boni Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boni Ding more than expected).

Fields of papers citing papers by Boni Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boni Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boni Ding. The network helps show where Boni Ding may publish in the future.

Co-authorship network of co-authors of Boni Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Boni Ding. A scholar is included among the top collaborators of Boni Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boni Ding. Boni Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Ziying, Yue Wang, Jiali Luo, et al.. (2025). Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 988–997. 1 indexed citations
2.
Zhong, Xiaoxiao, Huan Li, Xiangyu Shen, et al.. (2025). Glycosylated protein-related microenvironmental features in breast cancer are associated with patient prognosis. Mammalian Genome. 36(3). 884–902.
4.
Ding, Boni, et al.. (2024). Microplastics accumulated in breast cancer patients lead to mitophagy via ANXA2-mediated endocytosis and IL-17 signaling pathway. Environmental Pollution. 364(Pt 2). 125321–125321. 8 indexed citations
5.
Zhong, Xiaoxiao, et al.. (2022). Breast cancer combined with contralateral neck lymph node metastasis: a case report. Diagnostic Pathology. 17(1). 60–60.
6.
Ding, Boni, et al.. (2021). Safety of Breast Cancer Mastoscopic Surgery from the Perspective of Immunity and Adipokines. Journal of Investigative Surgery. 35(3). 632–638. 4 indexed citations
7.
Zhong, Xiaoxiao, Jun Li, Xin Wu, et al.. (2021). Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer. Frontiers in Oncology. 11. 742944–742944. 9 indexed citations
8.
Zhang, Juan, Jie Chen, Boni Ding, et al.. (2021). Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. European Journal of Cancer. 161. 10–22. 80 indexed citations
10.
Chen, Xisha, Kuan-Song Wang, Wei Guo, et al.. (2020). UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 10(4). 1833–1848. 37 indexed citations
11.
Gong, Ni, Runliu Wu, Boni Ding, & Wei Wu. (2020). ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA. Translational Cancer Research. 9(5). 3266–3273. 4 indexed citations
12.
Meng, Yang, Chen Zeng, Peiting Li, et al.. (2019). <p>Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells</p>. OncoTargets and Therapy. Volume 12. 3849–3858. 48 indexed citations
13.
Zhang, Qing, et al.. (2019). The Effect of Western Medicine Therapies on Granulomatous Mastitis: a Meta-analysis. Indian Journal of Surgery. 81(4). 366–378. 2 indexed citations
14.
Wu, Wei, Liyuan Qian, Jing Dai, Boni Ding, & Xuedong Chen. (2017). [Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].. PubMed. 42(2). 147–153. 9 indexed citations
15.
Li, Yun-Li, Lei Zhou, Xiaoxiao Li, et al.. (2017). [Parecoxib suppresses the increase of neutrophil-to-lymphocyte ratio after the modified radical mastectomy].. PubMed. 42(9). 1048–1052. 1 indexed citations
16.
Wu, Wei, Liyuan Qian, Xuedong Chen, & Boni Ding. (2015). Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.. PubMed. 8(10). 13217–24. 44 indexed citations
17.
Ding, Boni, Liyuan Qian, Yujun Zhao, Wei Wu, & Xuedong Chen. (2015). [Meta-analysis of endoscopic axillary lymph node dissection versus conventional open excision for breast cancer].. PubMed. 40(7). 782–9. 2 indexed citations
18.
Ding, Boni, Hongyan Zhang, Xiaorong Li, et al.. (2015). Mastoscopic sentinel lymph node biopsy in breastcancer. SHILAP Revista de lepidopterología. 10(1). 352–358. 3 indexed citations
19.
Ding, Boni, Daojin Chen, Xiaorong Li, Hongyan Zhang, & Yujun Zhao. (2013). [Meta analysis of efficacy and safety between mammotome minimally invasive operation and open excision for benign breast tumor].. PubMed. 38(3). 291–300. 1 indexed citations
20.
Ding, Boni, Daojin Chen, Xiaorong Li, Hongyan Zhang, & Yujun Zhao. (2013). Meta analysis of efficacy and safety between Mammotome vacuum-assisted breast biopsy and open excision for benign breast tumor.. PubMed. 2(2). 69–79. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026